Accessibility Statement for Biologic Medications

This is an accessibility statement from American Partnership for Eosinophilic Disorders (APFED) and the Allergy & Asthma Network (AAN).

Measures to support accessibility

American Partnership for Eosinophilic Disorders (APFED) and the Allergy & Asthma Network (AAN) takes the following measures to ensure accessibility of Biologic Medications:

  • Include accessibility as part of our mission statement.
  • Include accessibility throughout our internal policies.
  • Integrate accessibility into our procurement practices.
  • Assign clear accessibility goals and responsibilities.
  • Employ formal accessibility quality assurance methods.

Conformance status

The Web Content Accessibility Guidelines (WCAG) defines requirements for designers and developers to improve accessibility for people with disabilities. It defines three levels of conformance: Level A, Level AA, and Level AAA. Biologic Medications is partially conformant with WCAG 2.1 level AA. Partially conformant means that some parts of the content do not fully conform to the accessibility standard.

Additional accessibility considerations

Medical information has been written at a primary school level, although some medical terms are much higher on a cognitive scale.


We welcome your feedback on the accessibility of Biologic Medications. Please let us know if you encounter accessibility barriers on Biologic Medications:

We try to respond to feedback within 3 business days.

Compatibility with browsers and assistive technology

Biologic Medications is designed to be compatible with the following assistive technologies:

  • The technology is supported natively in widely-distributed user agents that are also accessibility supported (such as HTML and CSS)

Biologic Medications is not compatible with:

  • Browsers that are older than 2 major versions

Technical specifications

Accessibility of Biologic Medications relies on the following technologies to work with the particular combination of web browser and any assistive technologies or plugins installed on your computer:

  • HTML
  • CSS
  • JavaScript

These technologies are relied upon for conformance with the accessibility standards used.

Limitations and alternatives

Despite our best efforts to ensure accessibility of Biologic Medications , there may be some limitations. Below is a description of known limitations, and potential solutions. Please contact us if you observe an issue not listed below.

Known limitations for Biologic Medications:

  1. Embedded videos: Videos are embedded from YouTube because We currently do not have the resources to put an accessible player on our server at this time.. We are working on funding to remedy this issue. People can click on the YouTube link and see subtitles on YouTube’s website. We also provide a link to the transcript under each video.

Assessment approach

American Partnership for Eosinophilic Disorders (APFED) and the Allergy & Asthma Network (AAN) assessed the accessibility of Biologic Medications by the following approaches:

  • Self-evaluation

Formal complaints

We aim to respond to accessibility feedback within 3 business days, and to propose a solution within 10 business days.

Formal approval of this accessibility statement

This Accessibility Statement is approved by:
Kolleen Shallcross
SEO Specialist & WordPress Developer for Allergy & Asthma Network


This statement was created on 25 October 2022